Beone Medicines (ONC): Officer sold ~$1.16M
Chan Henry Lee, Officer at Beone Medicines, sold ~$1.16M of Beone Medicines shares.
- ~$1.16M
- Approx. value · 3,849 sh @ $301.00
- Traded
- Aug 13, 2025
- Filed
- Aug 15, 2025
What stands out in this filing
- The sale emptied this holding: the filing reports no shares left in it afterwards.
- 3,849 shares at an average of $301.00 each, as reported on the form.
- Footnote references a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 16, 2025Insider · 4 peopleInsiders: 5 sales (~$1.8M)
- Jun 17, 2025Insider · 3 peopleInsiders: 3 sales (~$651K)
- Jun 23, 2025Insider · 3 peopleInsiders: 4 sales (~$1.5M)
- Jun 24, 2025Insider · 1 personInsiders: 4 sales (~$533K)
- Jul 9, 2025Insider · 1 personInsiders: 4 sales (~$7.0M)
- Jul 18, 2025InsiderOfficer sold ~$210K of ONC shares in the open market
- Jul 29, 2025Insider · 1 personInsiders: 3 sales (~$1.2M)
- Jul 30, 2025Insider · 2 peopleInsiders: 2 sales (~$359K)
- Aug 1, 2025InsiderCFO sold ~$346K of ONC shares in the open market
- Aug 13, 2025 · this disclosureInsiderOfficer sold ~$1.16M of ONC shares in the open market
What came next
- Aug 13, 2025Insider · 2 peopleInsiders: 10 sales (~$17.3M)
- Aug 14, 2025Insider · 1 personInsiders: 8 sales (~$12.2M)
- Sep 2, 2025InsiderOfficer sold ~$40K of ONC shares in the open market
- Sep 5, 2025InsiderDirector sold ~$898K of ONC shares in the open market
- Sep 9, 2025Insider · Their largest sale since 2021Officer sold ~$1.75M of ONC shares in the open market
- Sep 10, 2025Insider · 1 personInsiders: 5 sales (~$3.3M)
- Sep 16, 2025Insider · 1 personInsiders: 5 sales (~$9.1M)
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 13, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Beone Medicines
For Beone Medicines, OQRO holds 34 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONC page.
Other recent filings by Chan Henry Lee, SVP, General Counsel
- SEC Form 4 at Beone Medicines (ONC)Nov 9, 2026
- SEC Form 4 at Beone Medicines (ONC)Nov 9, 2026
- SEC Form 4 at Beone Medicines (ONC)Oct 2, 2026
- SEC Form 4 at Beone Medicines (ONC)Sep 12, 2025
- SEC Form 4 at Beone Medicines (ONC)Sep 12, 2025
The full history of Chan Henry Lee, SVP, General Counsel is on the profile page.
How this filing works
Explore the data
Common questions
Which Beone Medicines (ONC) insider traded, and how much?
Chan Henry Lee, Officer at Beone Medicines, sold ~$1.16M of Beone Medicines shares. 3,849 shares at $301.00.
When did it happen, and when was it made public?
Traded: Aug 13, 2025. Filed: Aug 15, 2025. That is 2 days between the two dates.
What stands out in this filing?
The sale emptied this holding: the filing reports no shares left in it afterwards. 3,849 shares at an average of $301.00 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Beone Medicines recently?
For Beone Medicines, OQRO holds 34 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the ONC page.
Does this mean ONC stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Beone Medicines
- SEC Form 144Nov 19, 2026
- SEC Schedule 13GNov 13, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its ONC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
